Funding
← Back to your selection

CDP Venture Capital

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Biotech · Jul 27, 2026
Rounds participated in
2
Confirmed lead rounds
0
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$45.4M
1 disclosed · full round size, not this investor’s share

By stage

Seed1
Series C+1

By primary sector

Biotech2

By country

Italy1
Switzerland1

Rounds

2 in this selection
Nouscom

Clinical-stage biotech developing neoantigen-based cancer immunotherapies.

€120MSeries D
Participant